SCHEMBL29410552

SCHEMBL29410552

C=CC(=O)OC(O)(CCCCCCCO)OC(=O)C=C

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.39
ALDH1A1 P00352 4/20 0.39
CYP3A4 P08684 2/20 0.39
TP53 P04637 3/20 0.36
HIF1A Q16665 3/20 0.36
MAPK1 P28482 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CYP4F2 P78329 2/20 0.36
CYP4A11 Q02928 2/20 0.36
TDP1 Q9NUW8 1/20 0.33
HPGD P15428 1/20 0.32
HSD17B10 Q99714 1/20 0.31
GPR84 Q9NQS5 1/20 0.30
FFAR1 O14842 1/20 0.30
FFAR4 Q5NUL3 1/20 0.30
SMPD1 P17405 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29379507 1.00 TSHR (0.39) TSHRALDH1A1CYP3A4TP53HIF1A
SCHEMBL30422654 1.00 TSHR (0.39) TSHRALDH1A1CYP3A4TP53HIF1A
SCHEMBL29377110 0.96 TSHR (0.42) TSHRALDH1A1CYP3A4TP53HIF1A
SCHEMBL2530173 0.79 TSHR (0.43) TSHRALDH1A1CYP3A4TP53HIF1A
SCHEMBL28125584 0.76 TSHR (0.45) TSHRALDH1A1CYP3A4TP53HIF1A
SCHEMBL1408198 0.76 TSHR (0.41) TSHRALDH1A1CYP3A4TP53HIF1A
SCHEMBL29428358 0.74 TSHR (0.44) TSHRHPGDSMPD1
SCHEMBL30109516 0.73 CYP4F2 (0.39) TSHRALDH1A1CYP4F2CYP4A11TDP1
SCHEMBL29514777 0.73 CYP4F2 (0.39) TSHRALDH1A1CYP4F2CYP4A11TDP1
SCHEMBL29396000 0.73 CYP4F2 (0.39) TSHRALDH1A1CYP4F2CYP4A11TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4153598-A1 AZACOUMARIN AND AZATHIOCOUMARIN DERIVATIVES FOR USE IN OPTICALLY ACTIVE DEVICES AMO Ireland (IE) 2023-03-29 EP disclosed
EP-3958788-A1 SYSTEM AND METHOD Merck Patent GmbH (DE) 2022-03-02 EP disclosed